Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Rossignol

Showing results (41-50 of 541) with videos related to

Pageof 55
Sort By:
The American Journal of Cardiology|December 3, 2014
Do not analyze too quickly a result: how spironolactone is always point at!Romain Eschalier, Nicolas Girerd, Patrick Rossignol
International Journal of Cardiology|December 4, 2014
Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registriesPatrick Rossignol, Faiez Zannad, Bertram Pitt, et al.
JACC. Heart Failure|May 5, 2018
Reply: Carbohydrate Antigen-125 in Heart Failure: An Overlooked Biomarker of CongestionNicolas Girerd, Faiez Zannad, Patrick Rossignol, et al.
The New England Journal of Medicine|August 8, 2014
Fibrinolysis for intermediate-risk pulmonary embolismNicolas Girerd, Patrick Rossignol, Faiez Zannad
Hypertension (Dallas, Tex. : 1979)|September 10, 2019
Emerging Drug Classes and Their Potential Use in HypertensionMichel Azizi, Patrick Rossignol, Jean-Sébastien Hulot
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Hypertension in the elderly]Pierre-François Plouin, Patrick Rossignol, Guillaume Bobrie
European Journal of Heart Failure|June 1, 2018
Fibrosis mechanistic phenotyping and antifibrotic response determination with biomarkers in heart failure: one single biomarker may not fit all settingsPatrick Rossignol, João Pedro Ferreira, Faiez Zannad
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 20, 2019
Renin-angiotensin-aldosterone system and kidney interactions in heart failureJoão Pedro Ferreira, Patrick Rossignol, Faiez Zannad
Journal of the American Society of Nephrology : JASN|September 20, 2001
Atherosclerotic renal artery stenosis: to treat conservatively, to dilate, to stent, or to operate?Pierre-François Plouin, Patrick Rossignol, Guillaume Bobrie
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Selection of patients for surgery for primary aldosteronismPierre-François Plouin, Patrick Rossignol, Laurence Amar
Pageof 55

Showing results (41-50 of 541) with videos related to

Sort By:
Pageof 55
The American Journal of Cardiology|December 3, 2014
Do not analyze too quickly a result: how spironolactone is always point at!Romain Eschalier, Nicolas Girerd, Patrick Rossignol
International Journal of Cardiology|December 4, 2014
Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registriesPatrick Rossignol, Faiez Zannad, Bertram Pitt, et al.
JACC. Heart Failure|May 5, 2018
Reply: Carbohydrate Antigen-125 in Heart Failure: An Overlooked Biomarker of CongestionNicolas Girerd, Faiez Zannad, Patrick Rossignol, et al.
The New England Journal of Medicine|August 8, 2014
Fibrinolysis for intermediate-risk pulmonary embolismNicolas Girerd, Patrick Rossignol, Faiez Zannad
Hypertension (Dallas, Tex. : 1979)|September 10, 2019
Emerging Drug Classes and Their Potential Use in HypertensionMichel Azizi, Patrick Rossignol, Jean-Sébastien Hulot
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Hypertension in the elderly]Pierre-François Plouin, Patrick Rossignol, Guillaume Bobrie
European Journal of Heart Failure|June 1, 2018
Fibrosis mechanistic phenotyping and antifibrotic response determination with biomarkers in heart failure: one single biomarker may not fit all settingsPatrick Rossignol, João Pedro Ferreira, Faiez Zannad
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 20, 2019
Renin-angiotensin-aldosterone system and kidney interactions in heart failureJoão Pedro Ferreira, Patrick Rossignol, Faiez Zannad
Journal of the American Society of Nephrology : JASN|September 20, 2001
Atherosclerotic renal artery stenosis: to treat conservatively, to dilate, to stent, or to operate?Pierre-François Plouin, Patrick Rossignol, Guillaume Bobrie
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Selection of patients for surgery for primary aldosteronismPierre-François Plouin, Patrick Rossignol, Laurence Amar
Pageof 55